<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Hebestreit H</dc:creator>
  <dc:creator>Dibbert B</dc:creator>
  <dc:creator>Balatti I</dc:creator>
  <dc:creator>Braun D</dc:creator>
  <dc:creator>Schapowal A</dc:creator>
  <dc:creator>Blaser K</dc:creator>
  <dc:creator>Simon HU</dc:creator>
  <dc:date>1998</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">It has been suggested that Fas ligand-Fas receptor interactions are involved in the regulation of eosinophil apoptosis and that dysfunctions in this system could contribute to the accumulation of these cells in allergic and asthmatic diseases. Here, we demonstrate that nitric oxide (NO) specifically prevents Fas receptor-mediated apoptosis in freshly isolated human eosinophils. In contrast, rapid acceleration of eosinophil apoptosis by activation of the Fas receptor occurs in the presence of eosinophil hematopoietins. Analysis of the intracellular mechanisms revealed that NO disrupts Fas receptor-mediated signaling events at the level of, or proximal to, Jun kinase (JNK), but distal to sphingomyelinase (SMase) activation and ceramide generation. In addition, activation of SMase occurs downstream of an interleukin 1 converting enzyme-like (ICE-like) protease(s) that is not blocked by NO. However, NO prevents activation of a protease that targets lamin B1. These findings suggest a role for an additional NO-sensitive apoptotic signaling pathway that amplifies the proteolytic cascade initialized by activation of the Fas receptor. Therefore, NO concentrations within allergic inflammatory sites may be important in determining whether an eosinophil survives or undergoes apoptosis upon Fas ligand stimulation.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/22850</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1084/jem.187.3.415</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/9449721</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>The Journal of experimental medicine. - 1998</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Apoptosis</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Cell Survival</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Coculture Techniques</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Eosinophils</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Fas Ligand Protein</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Flow Cytometry</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Gene Expression Regulation, Neoplastic</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Histocytochemistry</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Immunoblotting</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Membrane Glycoproteins</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Nasal Polyps</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Nitric Oxide</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Nitric Oxide Synthase</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">RNA</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Second Messenger Systems</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">Signal Transduction</dc:subject>
  <dc:subject xmlns:ns18="xml" ns18:lang="en">Tumor Cells, Cultured</dc:subject>
  <dc:title xmlns:ns19="xml" ns19:lang="en">Disruption of fas receptor signaling by nitric oxide in eosinophils.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
